Literature DB >> 2714681

Dendritic cells and scavenger macrophages in chronic inflammatory bowel disease.

C A Seldenrijk1, H A Drexhage, S G Meuwissen, S T Pals, C J Meijer.   

Abstract

We used enzyme (acid phosphatase [AP]) and immunohistochemical techniques and a set of monoclonal antibodies (CD11, CD5, CD4, CD19, CD8, OKIa), including two recently developed antibodies--for example, HECA-452 (specific for an adhesion molecule on high endothelial venules) and RFD1 (specific for 'active' human dendritic cells) to analyse the composition of the gut wall infiltrate of 10 well defined cases of chronic inflammatory bowel disease (CIBD) (six Crohn's disease (CD), four ulcerative colitis (UC]. Two polar forms in a spectrum of gut mononuclear phagocyte types (CD11+) were identified: at the one extreme scavenger macrophages with blunted projections (AP+, Heca-452-, RFD1-) and at the other extreme, dendritic cells with long dendritic cytoplasmic projections (AP-, Heca-452+, RFD1+). Dendritic cells were mainly found in highly organised lymphoid tissue present at the deeper layers in the gut wall (normal gut: underneath the muscularis mucosae and T-cell areas of lymph follicles [25-30 per follicle]; surrounding the broad zone of scavenger macrophages at the bottom of ulcers (CIBD) and fissures (CD) and in the lymphoid aggregates [25-30 dendritic cells per aggregate] adjacent to granulomas (CD]. These observations can be taken as evidence that exaggerated antigen handling and presentation and stimulation of the immune response takes place at these foci. The observation that scavenger macrophages were localised more superficial, as band like zones (normal gut: subepithelial; mainly surrounding ulcers (CIBD) and fissures (CD] can be taken as evidence that at these spots the ingestion and degradation of foreign material takes place.

Entities:  

Mesh:

Year:  1989        PMID: 2714681      PMCID: PMC1434041          DOI: 10.1136/gut.30.4.486

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  Recurrent regional ileitis after ileostomy and colectomy for granulomatous colitis.

Authors:  B I Korelitz; D H Present; L I Alpert; R H Marshak; H D Janowitz
Journal:  N Engl J Med       Date:  1972-07-20       Impact factor: 91.245

2.  Antigen-bearing langerhans cells in skin, dermal lymphatics and in lymph nodes.

Authors:  I Silberberg-Sinakin; G J Thorbecke; R L Baer; S A Rosenthal; V Berezowsky
Journal:  Cell Immunol       Date:  1976-08       Impact factor: 4.868

3.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

4.  Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation.

Authors:  G Janossy; G Panayi; O Duke; M Bofill; L W Poulter; G Goldstein
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

5.  In situ localization of lymphocyte subsets in synovial membranes of patients with rheumatoid arthritis with monoclonal antibodies.

Authors:  C J Meijer; C B de Graaff-Reitsma; G J Lafeber; A Cats
Journal:  J Rheumatol       Date:  1982 May-Jun       Impact factor: 4.666

6.  High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452.

Authors:  A M Duijvestijn; E Horst; S T Pals; B N Rouse; A C Steere; L J Picker; C J Meijer; E C Butcher
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

7.  The involvement of interdigitating (antigen-presenting) cells in the pathogenesis of rheumatoid arthritis.

Authors:  L W Poulter; O Duke; S Hobbs; G Janossy; G Panayi; G Seymour
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

8.  Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen.

Authors:  R L Evans; D W Wall; C D Platsoucas; F P Siegal; S M Fikrig; C M Testa; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

9.  Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man.

Authors:  J A Ledbetter; R L Evans; M Lipinski; C Cunningham-Rundles; R A Good; L A Herzenberg
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

10.  Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells.

Authors:  C Y Wang; R A Good; P Ammirati; G Dymbort; R L Evans
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

View more
  22 in total

Review 1.  Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases.

Authors:  Madharasi V A Pichai; Lynnette R Ferguson
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

2.  Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis.

Authors:  M Y Choy; J A Walker-Smith; C B Williams; T T MacDonald
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

3.  Value of counting colonic mucosal Ig-containing cells in the differential diagnosis of chronic inflammatory bowel disease.

Authors:  C A Seldenrijk; S G Meuwissen; N W Schipper; B C Morson; J Lindeman; C J Meijer
Journal:  J Clin Pathol       Date:  1992-03       Impact factor: 3.411

4.  Possible involvement of muscularis resident macrophages in impairment of interstitial cells of Cajal and myenteric nerve systems in rat models of TNBS-induced colitis.

Authors:  Kazuya Kinoshita; Kazuhide Horiguchi; Masahiko Fujisawa; Fuyu Kobirumaki; Shigeru Yamato; Masatoshi Hori; Hiroshi Ozaki
Journal:  Histochem Cell Biol       Date:  2006-07-27       Impact factor: 4.304

Review 5.  Immunopathology of human inflammatory bowel disease.

Authors:  P Brandtzaeg; G Haraldsen; J Rugtveit
Journal:  Springer Semin Immunopathol       Date:  1997

6.  Immunohistochemical analysis of the distribution of measles related antigen in the intestinal mucosa in inflammatory bowel disease.

Authors:  M Iizuka; M Chiba; M Yukawa; T Nakagomi; T Fukushima; S Watanabe; O Nakagomi
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

7.  T-cell cytokines may control the balance of functionally distinct macrophage populations.

Authors:  V J Tormey; J Faul; C Leonard; C M Burke; A Dilmec; L W Poulter
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

8.  Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa.

Authors:  A Lamprecht; U Schäfer; C M Lehr
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

Review 9.  Intestinal drug delivery systems with biodegradable microspheres targeting mucosal immune-regulating cells for chronic inflammatory colitis.

Authors:  Kazuichi Okazaki; Hiroshi Nakase; Norihiko Watanabe; Yasuhiko Tabata; Yoshito Ikada; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

Review 10.  Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases.

Authors:  Wiebke Ulbrich; Alf Lamprecht
Journal:  J R Soc Interface       Date:  2009-11-25       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.